• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    2/14/24 3:42:33 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care
    Get the next $ALPA alert in real time by email
    SC 13G/A 1 form_sc13ga_carmellcorp.htm
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
     
     

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
     
     

    Carmell Corporation (f/k/a Alpha Healthcare Acquisition Corp. III)
    (Name of Issuer)
    Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
    142922103
    (CUSIP Number)
    December 31, 2023
    (Date of Event which Requires Filing of this Statement)
     
     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☒ Rule 13d-1(b) 
    ☐ Rule 13d-1(c) 
    ☐ Rule 13d-1(d) 
     
    *
    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No. 142922103
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Antara Capital LP
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
    (a) ☐ (b) ☒
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
    0
     
    6
     
    SHARED VOTING POWER
     
    371,250 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    371,250 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    371,250 (1)
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    1.6% (1)
    12
     
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN, IA
     
    (1)
    Includes 371,250 shares of Common Stock of the Issuer issuable upon the exercise of warrants that are beneficially owned by the reporting person. The numbers and percentage above reflect the beneficial ownership of the reporting person as of December 31, 2023.


    CUSIP No. 142922103
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Antara Capital GP LLC
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
    (a) ☐ (b) ☒
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    371,250 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    371,250 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    371,250 (1)
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    1.6% (1)
    12
     
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO
     
    (1)
    Includes 371,250 shares of Common Stock of the Issuer issuable upon the exercise of warrants that are beneficially owned by the reporting person. The numbers and percentage above reflect the beneficial ownership of the reporting person as of December 31, 2023.

    CUSIP No. 142922103
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Himanshu Gulati
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
    (a) ☐ (b) ☒
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    USA
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    371,250 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    371,250 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    371,250 (1)
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    1.6% (1)
    12
     
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN
     
    (1)
    Includes 371,250 shares of Common Stock of the Issuer issuable upon the exercise of warrants that are beneficially owned by the reporting person. The numbers and percentage above reflect the beneficial ownership of the reporting person as of December 31, 2023.


    Item 1(a)
    Name of Issuer:
    Carmell Corporation (f/k/a Alpha Healthcare Acquisition Corp. III) (the “Issuer”)
     
    Item 1(b)
    Address of Issuer’s Principal Executive Offices:
    2403 Sidney Street, Suite 300
    Pittsburgh, Pennsylvania 15203
     
    Item 2(a)
    Name of Person Filing:
    This Schedule 13G is being filed by
     
     (i)
    Antara Capital LP (“Antara Capital”)
     
     (ii)
    Antara Capital GP LLC (“Antara GP”)
     
     (iii)
    Himanshu Gulati (“Mr. Gulati”)
     
    Item 2(b)
    Address of Principal Business Office or, if None, Residence:
    The principal business address of each of the Reporting Persons is:
    55 Hudson Yards, 47th Floor, Suite C
    New York, NY 10001
     
    Item 2(c)
    Citizenship:
     
     (i)
    Antara Capital is a Delaware limited partnership
     
     (ii)
    Antara GP is a Delaware limited liability company
     
    (iii)
    Mr. Gulati is an individual and is a citizen of the United States.
     
    Item 2(d)
    Title of Class of Securities:
    Common Stock, par value $0.0001 per share (“Common Stock”)
     
    Item 2(e)
    CUSIP Number:
    142922103
     
    Item 3.
    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
    (a) ☐ Broker or dealer registered under Section 15 of the Exchange Act.
    (b) ☐ Bank as defined in section 3(a)(6) of the Exchange Act.
    (c) ☐ Insurance company as defined in section 3(a)(19) of the Exchange Act.
    (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940.
    (e) ☒ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). 
    (f) ☐ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). 
    (g) ☒ A parent holding company or control person in accordance with Rule 13d 1(b)(1)(ii)(G).
    (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
    (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940.
    (j) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(J). 
     
    Item 4.
    Ownership.
    Items 5 through 9 and 11 of each of the cover pages to this Schedule 13G are incorporated herein by reference.
    As of December 31, 2023, Antara Capital Total Return SPAC Master Fund LP (“SPAC Master Fund”) directly holds warrants to purchase 371,250 shares of Common Stock.
    As of December 31, 2023, the Reporting Persons in the aggregate beneficially own 1.6% of the shares of Common Stock outstanding, based on 23,081,642 shares of Common Stock of the Issuer outstanding as of November 14, 2023, based on the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 15, 2023, plus warrants to purchase 371,250 shares of Common Stock of the Issuer directly held by SPAC Master Fund.
    Antara GP is the general partner of Antara Capital. Antara Capital is the investment manager of the SPAC Master Fund. Mr. Gulati is the sole member of Antara GP. Antara Capital, Antara GP and Mr. Gulati may have been deemed to beneficially own the securities of the Issuer previously held directly by SPAC Master Fund.
     
    Item 5.
    Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable.
     
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
    Not applicable.
     
    Item 8.
    Identification and Classification of Members of the Group.
    Not applicable.

    Item 9.
    Notice of Dissolution of Group.
    Not applicable.
     
    Item 10.
    Certification.
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    February 14, 2024
     
         
    ANTARA CAPITAL LP
       
    By:
     
    Antara Capital GP LLC,
     
     
    its general partner
       
    By:
     
    /s/ Himanshu Gulati           
     
     
    Name: Himanshu Gulati
     
     
    Title: Managing Member
     
         
    ANTARA CAPITAL GP LLC
       
    By:
     
    /s/ Himanshu Gulati           
     
     
    Name: Himanshu Gulati
     
     
    Title: Managing Member
     
         
    By:
     
    //s/ Himanshu Gulati                                
     
     
    Name: Himanshu Gulati, an individual

    Get the next $ALPA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ALPA
    SEC Filings

    View All

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:27:40 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:14:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:07:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Shukla Rajiv was granted 14,347 shares and acquired 0 shares, increasing direct ownership by 42% to 48,526 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    1/4/24 9:17:09 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Frisch Scott M. bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:12:55 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful completion of its business combination (the "Business Combination") with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). The resulting combined company, Carmell Therapeutics Corporation, is expected to commence trading of its shares of common stock and warrants on the Nasdaq Capital Market® under the ticker symbols "CTCX" and "CTCXW," respectively, on July 17, 2023.

    7/14/23 3:12:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding letter of intent (the "LOI") to acquire a commercial stage regenerative medicine company (the "Target") conditioned upon the closing of ALPA's initial business combination with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). ALPA has set a Stockholders Meeting (the "Meeting") to consider the previously announced business combination with Carmell for J

    6/27/23 7:00:00 AM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a definitive business combination agreement with Carmell Therapeutics Corporation ("Carmell™"), a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications. Upon closing of the transaction, ALPA will be renamed Carmell Therapeutics Corporation (the "Combined Company"). Mr. Shukla will serve as Chairman and Mr. Randy Hubbell will serve as Chief Executive Officer of the Combined Company. The Combined Company's common stock is expected to be listed on the Na

    1/4/23 10:11:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 4:13:13 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 3:42:33 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III

    SC 13G - Carmell Corp (0001842939) (Subject)

    2/14/24 12:54:27 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care